Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

NCT07000084 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Non-Muscle Invasive Bladder Carcinoma
Stage 0a Bladder Cancer AJCC v8
Stage I Bladder Cancer AJCC v8

Interventions

BIOLOGICAL: BCG Solution
PROCEDURE: Biopsy of Bladder
PROCEDURE: Cystoscopy
PROCEDURE: Computed Tomography
PROCEDURE: Magnetic Resonance Imaging
PROCEDURE: Biospecimen Collection
PROCEDURE: Transurethral Resection of Bladder Tumor
DRUG: Gemcitabine

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]